
Emily Finklestein
Advertisement
Articles by Emily Finklestein

Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Frontline Giredestrant Displays IDFS Improvement vs SOC ET in ER+/HER2– BC
2
Sacituzumab Govitecan Does Not Meet Statistical Significance in HR+/HER2– mBC
3
QOL Improvements Noted After CAR T-Cell Therapy in LBCL
4
Belantamab Mafodotin Combo Sustains MRD Negativity/PFS in Multiple Myeloma
5


